The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy. (2023)

First Author: Banerji CRS
Attributed to:  Understanding and Ameliorating Pathogenesis in FSHD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcad221

PubMed Identifier: 37731904

Publication URI: http://europepmc.org/abstract/MED/37731904

Type: Journal Article/Review

Volume: 5

Parent Publication: Brain communications

Issue: 5

ISSN: 2632-1297